Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: The relationship between nadir level and disease-free survival

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 450-453

  Lee, W Robert ^a   Hanlon, Alexandra L ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Neoplasm antigens; Prostate specific antigen; Prostatic neoplasms; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ARTICLE; BLOOD; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; PROSTATE TUMOR; RADIOTHERAPY; STATISTICAL ANALYSIS;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY;

EID: 0030211265     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65876-2     Document Type: Article

References (14)

1. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
2. Lee, W. R., Hanks, G. E., Schultheiss, T. E., Corn, B. W. and Hunt, M. A.: Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen - driven outcome analysis. J. Clin. Oncol., 13: 464, 1995.
3. Zeitman, A. L., Coen, J. J., Shipley, W. U., Willett, C. G. and Efird, J. T.: Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. J. Urol., 151: 640, 1994.
4. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
5. Hanks, G. E., D'Amico, A., Epstein, B. E. and Schultheiss, T. E.: Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time. Int. J. Rad. Oncol. Biol. Phys., 27: 125, 1993.
6. Pollack, A., Zagars, G. K. and Kavadi, V. S.: Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer, 74: 670, 1994.
7. Partin, A. W., Pearson, J. D., Landis, P. K., Carter, H. B., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology, 43: 649, 1994.
8. Zagars, G. K., Sherman, N. E. and Babaian, R. J.: Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer, 67: 412, 1991.
9. Kavadi, V. S., Zagars, G. K. and Pollack, A.: Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. Int. J. Rad. Oncol. Biol. Phys., 30: 279, 1994.
10. Tibbs, M. K., Zeitman, A. L., Dallow, K. C., Althausen, A. F., Heney, N. M. and Shipley, W. U.: Biochemical outcome following external beam radiation therapy for T1-2 prostate carcinoma: the importance of achieving an undetectable nadir PSA. Int. J. Rad. Oncol. Biol. Phys., suppl. 1, 32: 230, 1995.
11. American Joint Committee on Cancer: Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott Co., 1992.
12. Corn, B. W., Hanks, G. E., Schultheiss, T. E., Hunt, M. A., Lee, W. R. and Coia, L. R.: Conformai treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int. J. Rad. Oncol. Biol. Phys., 32: 325, 1995.
13. Kaplan, I. D., Cox, R. S. and Bagshaw, M. A.: Prostate specific antigen after external beam radiotherapy for prostate cancer: followup. J. Urol., 149: 519, 1993.
14. Hanks, G. E., Perez, C. A., Kozar, M., Asbell, S. O., Pilepich, M. V. and Pajak, T. F.: PSA confirmation of cure at 10 years of T1b, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation. Int. J. Rad. Oncol. Biol. Phys., 30: 289, 1994.